(Q34962208)

5 August 2017

1 reference

title

Are all antihypertensive drug classes equal in reducing left ventricular hypertrophy? (English)

1 reference

5 August 2017

Erwin H Fleischmann

1

1 reference

5 August 2017

Roland E Schmieder

series ordinal

2

1 reference

5 August 2017

publication date

1 November 2002

1 reference

Current cardiology reports

5 August 2017

published in

1 reference

5 August 2017

volume

4

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

474-478

1 reference

https://scigraph.springernature.com/pub.10.1007/s11886-002-0109-2

5 August 2017

exact match

0 references

cites work

Echocardiographically detected left ventricular hypertrophy: prevalence and risk factors. The Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0109-2

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0109-2

Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0109-2

Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0109-2

Effects of mechanical forces on signal transduction and gene expression in endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0109-2

Calcineurin and beyond: cardiac hypertrophic signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0109-2

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11886-002-0109-2

Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload.

21 January 2018

1 reference

12 December 2020

Comparison of therapeutic studies on regression of left ventricular hypertrophy.

1 reference

12 December 2020

The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group

1 reference

12 December 2020

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies

1 reference

12 December 2020

Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)

1 reference

12 December 2020

Standardization of M-mode echocardiographic left ventricular anatomic measurements

1 reference

12 December 2020

The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease

1 reference

12 December 2020

Inadequate suppression of angiotensin II modulates left ventricular structure in humans

1 reference

12 December 2020

Regression of left ventricular hypertrophy in human hypertension with irbesartan.

1 reference

12 December 2020

Different effects of fosinopril and atenolol on wave reflections in hypertensive patients

1 reference

12 December 2020

Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension

1 reference

12 December 2020

Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies

1 reference

12 December 2020

Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.

1 reference

12 December 2020

Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The framingham heart study

1 reference

12 December 2020

Effect of the angiotensin II type 2-receptor gene (+1675 G/A) on left ventricular structure in humans

1 reference

12 December 2020

Contrast in cardiac anatomy and function between black and white patients with hypertension.

1 reference

12 December 2020

Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).

1 reference

12 December 2020

Association of echocardiographic left ventricular mass with body size, blood pressure and physical activity (the Framingham Study)

1 reference

12 December 2020

Relation of arterial pressure waveform to left ventricular and carotid anatomy in normotensive subjects

1 reference

12 December 2020

Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension

1 reference

12 December 2020

Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial

1 reference

12 December 2020

Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents

1 reference

12 December 2020

Dietary salt intake. A determinant of cardiac involvement in essential hypertension

1 reference

12 December 2020

10.1007/S11886-002-0109-2

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

1026272656

0 references

1 reference